CELZ 13F Investor Activity Report

Creative Medical Technology Holdings (CELZ) convinced holders of its existing warrants to exercise them early by lowering the exercise price from $2.86 to $1.60 per share, generating about $4.5 million in gross proceeds. In exchange, the company issued new warrants for over 5.5 million additional shares at the same reduced price, but those new warrants can't be used until stockholders approve. The cash will go toward working capital and general corporate purposes.